Beyond Barriers Therapeutics is developing a novel product to treat inflammation and cell death following traumatic brain injury (TBI). Building upon promising research from the National Institutes of Health, our product uses a unique mechanism to deliver therapeutic drugs to the brain.
Because of a lack of specific therapies for TBI, patients receive care consisting mainly of passive monitoring and a "wait and see" approach. We are developing a treatment that would actively help reduce secondary damage to neural tissue following injury.
Opening new pathways for tomorrow's clinical breakthroughs